1933 Industries Appoints Mr. Paul Rosen to its Board of Directors

Working closely alongside Eugene Ruiz, President of the Company, we are steering the business at a critical junction, instituting prudent financial controls, reigning in spending and shoring up the balance sheet Mr. Paul Rosen BC, – 1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), a vertically-integrated cannabis consumer packaged goods company with a diverse portfolio of consumer-driven brands,Continue reading “1933 Industries Appoints Mr. Paul Rosen to its Board of Directors”

EnWave Announces 2020 Third Quarter Consolidated Interim Financial Results and Corporate Strategy Update

#ENW Highlights for Q3 Revenue from EnWave in Q3 2020 was $1,609 (expressed in ‘000s) compared to $5,075 in Q3 2019, a decrease of $3,466 or 68%. The decrease in revenue was due to a slowdown in large-scale Radiant Energy Vacuum (“REVTM”) machinery sales primarily to cannabis royalty partners. Reduced company-wide overhead expenses by $1.0Continue reading “EnWave Announces 2020 Third Quarter Consolidated Interim Financial Results and Corporate Strategy Update”

Plus Products Reports Second Quarter 2020 Financial Results

Calif., Aug. 20, 2020-Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a cannabis branded products company in the U.S., released its unaudited financial and operational results for the three and six months ended June 30, 2020, expressed in U.S. dollars. These filings are available for review on the Company’s SEDAR profile at http://www.sedar.com and on theContinue reading “Plus Products Reports Second Quarter 2020 Financial Results”

Canopy Rivers Announces AGM Date

TORONTO, Aug. 18, 2020 – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) will hold its annual general and special meeting of shareholders of the Company (“Shareholders“) on September 24, 2020 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Company’s profile on the System for Electronic Document Analysis and Retrieval orContinue reading “Canopy Rivers Announces AGM Date”

Ayr Strategies Positioned to Expand Footprint in Nevada Following Settlement Agreement

TORONTO, Aug. 11, 2020 (GLOBE NEWSWIRE) — Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRSF) (“Ayr”), a vertically-integrated cannabis multi-state operator (MSO), today announced it has been awarded two additional dispensary licenses in the greater Las Vegas market, one in Clark County and one in Henderson, as part of a settlement in connection with the disputedContinue reading “Ayr Strategies Positioned to Expand Footprint in Nevada Following Settlement Agreement”

WeedMD Enters into Commercial Arrangement with Fire & Flower to produce CBD Cannabis Products

Fire & Flower’s Revity CBD private label brand produced by CX Industries launches in Saskatchewan cannabis retail stores Commercial Arrangement made making, packaging, and shipping CBD line regulated CBD products an underserved market TORONTO, – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has entered into a commercialContinue reading “WeedMD Enters into Commercial Arrangement with Fire & Flower to produce CBD Cannabis Products”

Health Canada Requests Protocol Details of COVID-19 Phase 2 Clinical Trial

– TheNewswire – August 10, 2020 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) advises that subsequent to Heath Canada issuing a No Objection Letter, they have requested specific protocol details regarding the Clinical Trial Application for CavaltinibTM, the target drug of the proposed joint venture with Biologic Pharmaceutical Research, before the trial may commence.Continue reading “Health Canada Requests Protocol Details of COVID-19 Phase 2 Clinical Trial”

Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone

Company surpasses 1,000 medical cannabis patient prescriptions in Colombia in the first 10 weeks of sales activity, representing a milestone towards meeting patient needs in Latin America and globally Company prudently managing financial resources through reduced expenses and held approximately $20 Million in cash at the end of June 2020, after closing Q1 with $24 Million and Q4 2019 with $36 Million Received authorization forContinue reading “Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone”

MediPharm Labs Selected by University Health Network and Medical Cannabis by Shoppers Inc. for First Real-World Evidence, Patient-Centred Clinical Trial Using Blockchain Technology

~20% of UHN products in study formulary, including 7 unique medical cannabis products, to be manufactured by MediPharm Labs  — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its participation in a ground-breaking collaboration between University Health Network (“UHN”) and MedicalContinue reading “MediPharm Labs Selected by University Health Network and Medical Cannabis by Shoppers Inc. for First Real-World Evidence, Patient-Centred Clinical Trial Using Blockchain Technology”